Rowan University

MRIMath's AI-Powered Glioblastoma Tool Receives FDA Clearance

6 months ago

• MRIMath LLC's _i_ 2Contour, an AI-powered tool for glioblastoma mapping and measurement, has received FDA clearance, allowing its marketing to potential customers. • The tool, co-developed by Rowan University and the University of Alabama at Birmingham, aims to improve efficiency and accuracy in tumor contouring, potentially reducing healthcare costs. • _i_ 2Contour uses AI trained on MRI images to delineate tumor boundaries, assess previous scans, and predict tumor growth, enabling earlier detection and response to tumor development. • The technology has garnered interest from universities and hospital systems, with potential to improve patient outcomes in glioblastoma treatment.